Are serum oxytocin concentrations lower in patients with treatment-resistant schizophrenia?: A 5-year longitudinal study

被引：1
|
作者：
Kanahara, Nobuhisa [1 ]
Nakamura, Miwako [2 ]
Shiko, Yuki [3 ]
Kawasaki, Yohei [3 ]
Iyo, Masaomi [2 ]
机构：
[1] Chiba Univ, Div Med Treatment & Rehabil, Ctr Forens Mental Hlth, 1-8-1 Inohana, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan
[3] Chiba Univ Hosp, Clin Res Ctr, Biostat Sect, Chiba, Japan
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2022年 / 76卷
关键词：
Clozapine; ELISA; GABA; CEREBROSPINAL-FLUID;
D O I：
10.1016/j.ajp.2022.103157
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] 5-YEAR TRIAL OF DIALYTIC TREATMENT FOR SCHIZOPHRENIA
    SPLENDIANI, G
    BRUNO, V
    MARINANGELI, G
    CUPILLARI, M
    CIRELLI, C
    TANCREDI, M
    ARTIFICIAL ORGANS, 1983, 7 (03) : 322 - 325
  • [22] A 5-YEAR LONGITUDINAL-STUDY OF PATIENTS TREATED WITH OVERDENTURES
    TOOLSON, LB
    SMITH, DE
    JOURNAL OF PROSTHETIC DENTISTRY, 1983, 49 (06): : 749 - 756
  • [23] Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study
    Kumazaki, Hirokazu
    Kobayashi, Hiroyuki
    Niimura, Hidehito
    Kobayashi, Yasushi
    Ito, Shinya
    Nemoto, Takahiro
    Sakuma, Kei
    Kashima, Haruo
    Mizuno, Masafumi
    COMPREHENSIVE PSYCHIATRY, 2012, 53 (07) : 946 - 951
  • [24] Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
    Krivoy, Amir
    Whiskey, Eromona
    Webb-Wilson, Henrietta
    Joyce, Dan
    Tracy, Derek K.
    Gaughran, Fiona
    MacCabe, James H.
    Shergill, Sukhwinder S.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11
  • [25] Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia
    Kane, JM
    Khanna, S
    Rajadhyaksha, S
    Giller, E
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (01) : 21 - 28
  • [26] Efficacy of clozapine for long-stay patients with treatment-resistant schizophrenia: 4-year observational study
    Mizuno, Kentaro
    Mizuno, Emiko
    Suekane, Akira
    Shiratsuchi, Toshiaki
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2022, 42 (02) : 183 - 190
  • [27] Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia
    Ucok, Alp
    Yagcioglu, Elif Anil
    Yildiz, Mustafa
    Kaymak, Semra Ulusoy
    Saka, Meram Can
    Tasdelen, Rumeysa
    Danaci, Aysen Esen
    Senol, Sevin Hun
    PSYCHIATRY RESEARCH, 2019, 275 : 149 - 154
  • [28] Profiling cognitive impairment in treatment-resistant schizophrenia patients
    Frydecka, Dorota
    Beszlej, Jan Aleksander
    Goscimski, Piotr
    Kiejna, Andrzej
    Misiak, Blazej
    PSYCHIATRY RESEARCH, 2016, 235 : 133 - 138
  • [29] Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia
    Hashimoto, K.
    Sudo, T.
    Hirano, M.
    Motomura, H.
    Tagawa, K.
    Nashiro, S.
    Uemura, K.
    Yoshimoto, S.
    SCHIZOPHRENIA RESEARCH, 2006, 87 (1-3) : 332 - 333
  • [30] Evaluating sexual function in patients with treatment-resistant schizophrenia
    Kelly, DL
    Conley, RR
    SCHIZOPHRENIA RESEARCH, 2003, 63 (1-2) : 195 - 196
12345